NAFLD and liver-related events: does type 2 diabetes have a key role?

Affiliations

Comment

Eduardo Vilar-Gomez. Lancet Gastroenterol Hepatol. 2023 Sep.

. 2023 Sep;8(9):777-778.

doi: 10.1016/S2468-1253(23)00187-5. Epub 2023 Jul 4.

¹ Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Electronic address: evilar@iu.edu.

No abstract available

Conflict of interest statement

I declare no competing interests.

Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis.
Huang DQ, Noureddin N, Ajmera V, Amangurbanova M, Bettencourt R, Truong E, Gidener T, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Yoneda M, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Allen AM, Noureddin M, Loomba R. Huang DQ, et al. Lancet Gastroenterol Hepatol. 2023 Sep;8(9):829-836. doi: 10.1016/S2468-1253(23)00157-7. Epub 2023 Jul 4. Lancet Gastroenterol Hepatol. 2023. PMID: 37419133 Free PMC article.